Diabetic nephropathy: preventing progression - Wikidata - awgldk - TriplyDB

Diabetic nephropathy: preventing progression

Diabetic nephropathy: preventing progression

http://www.wikidata.org/entity/Q33850444

about

Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.Psoralea corylifolia L. Seed Extract Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis and Apoptosis in Streptozotocin-Induced Diabetic Mice.

P2860

Q33761954-60628B5D-FE2F-43CC-8A43-496558225E57 Q41583942-6B92BFB8-E229-4829-A9A8-BF923C77C5EC

P2860

Diabetic nephropathy: preventing progression

http://www.wikidata.org/entity/Q33850444

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Diabetic nephropathy: preventing progression

@ast

Diabetic nephropathy: preventing progression

@en

type

label

Diabetic nephropathy: preventing progression

@ast

Diabetic nephropathy: preventing progression

@en

prefLabel

Diabetic nephropathy: preventing progression

@ast

Diabetic nephropathy: preventing progression

@en

P1433

Q33850444-ACAF1028-0459-47D2-94D3-CBF7A27CCFD7

P1476

Q33850444-B9CC6950-9945-4161-81B8-5515D52C7C11

P2860

Q33850444-042242BE-1058-47A3-9113-8FA724CCE94A

Q33850444-04C2564C-1FD2-49E2-93BF-B8730530E964

Q33850444-0C8E9093-A4D0-4E10-A3AC-C699D34A8BC1

Q33850444-188FDC6E-B884-49CB-A1E1-2530D14B4DB0

Q33850444-436E5829-B41C-4477-AC0B-94A619212FA9

Q33850444-43A79904-6F3A-4DFE-96FC-F083FB0C75C7

Q33850444-710A3023-18CD-4957-83D5-B28C85F8B75A

Q33850444-7DD8510B-B668-47A9-B199-D00488596C23

Q33850444-96FC0458-63F5-4E44-844D-DEC5AFB4249D

Q33850444-97D7B787-4DCE-43AE-8151-2A9162AC93E3

P31

Q33850444-15F8D670-6EE8-4A97-8643-0889162DCA68

P478

Q33850444-17777701-549B-4A5B-81B7-4FE2BED575F8

P50

Q33850444-4467EC18-1E82-4AF3-92F1-CF3F095CF272

P577

Q33850444-8C567D7A-F180-44ED-B07A-6EACA61D3BA8

P698

Q33850444-C77A1E4D-3ADE-4AF2-B66C-279A66D1F2B2

P932

Q33850444-F03F1EF6-ED59-441E-AF99-6C57F2B59118

P1433

Clinical Evidence

P1476

Diabetic nephropathy: preventing progression

@en

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data.

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.

The need and demand for renal replacement therapy in ethnic minorities in England

Clinical practice. Nephropathy in patients with type 2 diabetes.

P31

scholarly article

P478

2010

http://www.w3.org/2001/XMLSchema#string

P50

Michael G Shlipak

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21418671

http://www.w3.org/2001/XMLSchema#string

P932

3217768

http://www.w3.org/2001/XMLSchema#string